Australia Nephrology and Urology Devices Market Outlook to 2025 - Renal Dialysis Equipment

Table of Contents

• 1.1 List of Tables 4
• 1.2 List of Figures 4

2 Introduction 5

• 2.1 What Is This Report About? 5
• 2.2 Nephrology and Urology Devices Market Segmentation 5
• 2.3 Definitions of Markets Covered in the Report 6

3 Nephrology and Urology Devices Market, Australia 8

• 3.1 Nephrology and Urology Devices Market, Australia, Revenue ($m), 2015-2025 8
• 3.2 Nephrology and Urology Devices Market, Australia, Revenue ($m), 2015-2025 9
• 3.3 Nephrology and Urology Devices Market, Australia, Volume (Units), 2015-2025 11
• 3.4 Nephrology and Urology Devices Market, Australia, Volume (Units), 2015-2025 12
• 3.5 Nephrology and Urology Devices Market, Australia, Company Share by Revenue ($m), 2019 14

4 Renal Dialysis Equipment Market, Australia 16

• 4.1 Renal Dialysis Equipment Market, Australia, Revenue Mix ($m), 2019 16
• 4.2 Renal Dialysis Equipment Market, Australia, Segment Contribution (%), 2019 17
• 4.3 Renal Dialysis Equipment Market, Australia, Revenue ($m), 2015-2025 18
  • 4.3.1 Dialysis Accessories Market, Australia, Revenue ($m), by Segment, 2015-2025 20
  • 4.3.2 Dialysis Machines Market, Australia, Revenue ($m), by Segment, 2015-2025 23
  • 4.3.3 Vascular Access Devices for Hemodialysis Market, Australia, Revenue ($m), by Segment, 2015-2025 25
• 4.4 Renal Dialysis Equipment Market, Australia, Volume (Units), 2015-2025 28
  • 4.4.1 Dialysis Accessories Market, Australia, Volume (Units) by Segment, 2015-2025 30
  • 4.4.2 Dialysis Machines Market, Australia, Volume (Units) by Segment, 2015-2025 33
  • 4.4.3 Vascular Access Devices for Hemodialysis Market, Australia, Volume (Units) by Segment, 2015-2025 35
• 4.5 Renal Dialysis Equipment Market, Australia, Average Price ($), 2015-2025 38
• 4.6 Renal Dialysis Equipment Market, Australia, Distribution Share by Revenue ($m), 2019 40
• 4.7 Renal Dialysis Equipment Market, Australia, Company Share by Revenue ($m), 2019 41

5 Overview of Key Companies in Australia, Nephrology and Urology Devices Market 43

• 5.1 Fresenius Medical Care AG & Co KGaA 43
  • 5.1.1 Company Overview 43
• 5.2 Baxter International Inc 43
  • 5.2.1 Company Overview 43
• 5.3 Nipro Corp 43
  • 5.3.1 Company Overview 43
• 5.4 B. Braun Melsungen AG 44
  • 5.4.1 Company Overview 44
• 5.5 Asahi Kasei Corp 44
  • 5.5.1 Company Overview 44
• 5.6 Toray Medical Co Ltd 44
  • 5.6.1 Company Overview 44
• 5.7 CR Bard Inc 45
  • 5.7.1 Company Overview 45

6 Nephrology and Urology Devices Market Pipeline Products 46

7 Financial Deals Landscape 48

• 7.1 Debt Offerings 48
  • 7.1.1 Simavita Raises USD0.3 Million in First Tranche of Private Placement of Notes 48
• 7.2 Equity Offerings 49
  • 7.2.1 Simavita Raises USD1.3 Million in Private Placement of CHESS Depository Interests 49
  • 7.2.2 Simavita Raises USD0.7 Million in Private Placement of CHESS Depository Interests 50
  • 7.2.3 Analytica to Raise USD1.88 Million in Rights Offering of Shares 51

8 Recent Developments 52

• 8.1 Corporate Communications 52
  • 8.1.1 Dec 16, 2019: Simavita secures commitment for $508,800 financing by way of Receivable Finance Facility 52
  • 8.1.2 Jul 23, 2019: Simavita: Changes to the board of directors 52
  • 8.1.3 Jul 19, 2019: Penthrox USA update 52
  • 8.1.4 May 13, 2019: Bioness announces first Australian implant of StimRouter Neuromodulation System at Nambour Selangor Private Hospital 53
• 8.2 Financial Announcements 54
  • 8.2.1 Oct 31, 2019: Simavita releases ASX Appendix 4C for the quarter ended September 30, 2019 54
  • 8.2.2 Sep 17, 2019: Novita signs key UK partner supply agreement 55
  • 8.2.3 Jul 31, 2019: Analytica: Appendix 4c -quarterly cash flow report for 30th June 2019 57
  • 8.2.4 Jul 17, 2019: Simavita reports half-year financial results 57
  • 8.2.5 Apr 30, 2019: Analytica: Appendix 4C - Quarterly cash flow report for 31st March 2019 59
• 8.3 Other Significant Developments 60
  • 8.3.1 Jul 31, 2019: Simavita releases ASX appendix 4C for the quarter ended June 30, 2019 60
  • 8.3.2 Apr 30, 2019: Simavita releases appendix 4C for the quarter ended March 31, 2019 60

9 Appendix 62

• 9.1 Research Methodology 63
  • 9.1.1 Coverage 63
  • 9.1.2 Secondary Research 63
  • 9.1.3 Primary Research 64
  • 9.1.4 Market Modeling and Forecasting 64
  • 9.1.5 Company Share Analysis 66
  • 9.1.6 Distribution Share Analysis 66
  • 9.1.7 Benchmarking 67
• 9.2 GlobalData Consulting 67
• 9.3 Contact Us 68